Clinical prediction scores based on preoperative data correlated with visual acuity and visual function scores after phacoemulsification, a study found.
Knowing Your Risks Can Stop The Sneak Thief Of Sight
Glaucoma is a silent illness; most people have no early symptoms and do not notice as their peripheral vision diminishes or blind spots occur. The disease affects more than 2.3 million Americans age 40 and older. Another 2 million do not know they have…
Blue-Blocking IOL’s- A Bad Idea?
In an editorial in Ophthalmology, the authors are very critical of the lack of scientific evidence that blue-blocking IOL’s are of any value in reducing the progression of macular degeneration. They agree with the CMS that the relationship between blue light and AMD is speculative and not evidence-based. The authors make a compelling point. I […]
CATT Study Update 12: Status of WorldWide Studies
With the anticipated arrival of the one-year results of the CATT Study this Spring, I thought it would be appropriate to update where the other worldwide studies stand.During the Retina Subspecialty Day sessions, held prior to the recent 2010 AAO Meeti…
Stem Cell Trial For AMD Approved
A clinical trial of a human embryonic stem cell (ESC) therapy for age-related macular degeneration has been approved by the FDA, making it the first such study for a common disease.
Resequencing Chip Enables Rapid Detection Of Mutations In Retinal Disease Genes
A custom resequencing chip accurately and efficiently identified novel and known mutations in retinal disease genes in multiple patients, a study conducted in the Netherlands found.